EB
Insider
Eric Benevich
Chief Commercial OfficerEric Benevich (Chief Commercial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $906K of NBIX (5,970 sh × $151.74, as filed), executed Nov 28 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.2M
shares × price, as filed
Last traded
Sep 9
Filed Sep 10
Median ADV $194.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
NBIX
Neurocrine Biosciences, Inc.
NBIX · 0 buys · 5 sells
5 filings
Recent filings
NBIXSALE
Neurocrine Biosciences, Inc.
View filing →
$333K2,154 sh × $154.61
Exec Sep 9
Filed Sep 10 · 8:29 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $906K
5,970 sh × $151.74
Exec Nov 28 2025
Filed Dec 2 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $251K
2,154 sh across 2 lots
Exec Feb 13 2025
Filed Feb 14 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $116K
980 sh × $118.31
Exec Feb 10 2025
Filed Feb 12 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $185K
1,207 sh × $152.94
Exec Jan 31 2025
Filed Feb 4 2025 · 5:30 PM ET